Literature DB >> 7549206

Partial volume effects in volume-localized phased-array proton spectroscopy of the temporal lobe.

W L Strauss1, J S Tsuruda, T L Richards.   

Abstract

MRS techniques can aide in confirming the location of seizure foci in temporal lobe epilepsy. N-acetyl aspartate (NAA), creatine plus phosphocreatine, choline-containing compounds, and lactate are most often the clinically relevant metabolites in these studies. We examined the importance of partial volume effects from tissue heterogeneity in temporal lobe spectroscopy on the metabolite ratios. Our study shows that localized spectroscopy, using three different voxel sizes, centered on the anterior body of the hippocampus, produces significantly different values for the NAA to the creatine ratio. The spectroscopy was performed at 1.5 T using the PRESS pulse sequence and a phased-array coil system specifically designed for the temporal lobe. The data exhibits a clear trend of increasing NAA to creatine ratios with increasing voxel size. This trend demonstrates that partial volume effects can contribute to variation of NAA to creatine ratios in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549206     DOI: 10.1002/jmri.1880050411

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  3 in total

1.  Localized proton MR spectroscopy of the allocortex and isocortex in healthy children.

Authors:  C G Choi; T S Ko; H K Lee; J H Lee; D C Suh
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

Review 2.  1H MR spectroscopy in patients with mesial temporal epilepsy.

Authors:  M Hájek; M Dezortová; V Komárek
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

3.  Fire-related post-traumatic stress disorder: brain 1H-MR spectroscopic findings.

Authors:  Myung Kwan Lim; Chang Hae Suh; Hyung Jin Kim; Sung Tae Kim; Jeong Seop Lee; Min Hee Kang; Ji Hye Kim; Jung Hee Lee
Journal:  Korean J Radiol       Date:  2003 Apr-Jun       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.